Long-term running data not associated with arthritis risk: The marathon study

Published Date: 17 Mar 2023

A group of researchers from the annual meeting of the American Academy of Orthopedic Surgeons (AAOS) "analyzed the data and...

Read Full News

Latest News

Study Finds Huge Regional Variability in 'Low-Value' Orthopedic Services for Vets

— Patients in one place may get Medicare-paid procedures 10 times as often as elsewhere

Study 'Challenges' Standard of Prolonged Antibiotics for Orthopedic Infections

— Local antibiotic implants during surgery may have helped shorten postoperative systemic regimens

One Active Joint Left in Inflammatory Arthritis: What to Do?

Despite being a clinical scenario familiar to any rheumatologist, little evidence exists to guide treatment decisions for inflammatory arthritis limited to a single major joint.

AbbVie's Blood Cancer Therapy Lowers Disease Progression, Death Risk in Trial

AbbVie said on Thursday its therapy for a type of blood cancer has improved patients' response rate ⁠to treatment and reduced the risk of disease progression or death,...

Less Frequent Monitoring May Be Safe in Patients on MTX

For patients on methotrexate, routine monitoring every 6 months vs 3 months is not linked to an increase in laboratory or blood count abnormalities.

Gout Tied to Elevated Fracture Risk; Drug Adherence Helps

A recent diagnosis of gout is associated with an increased risk for fractures, and high adherence to allopurinol may help mitigate this elevated risk.

Todays Updates

Trappsol Cyclo Misses Primary End Point in Phase 3 Trial for Niemann-Pick Disease Type C Isabella Ciccone, MPH

Findings from the phase 3 TransportNPC study showed that Trappsol Cyclo missed the primary end point in Niemann-Pick type C, but subgroup and survival data support planned 2026 NDA.

NeurologyLive® Friday 5 — October 2, 2026 Isabella Ciccone, MPH

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending October 2, 2026.

Todays Updates

Trappsol Cyclo Misses Primary End Point in Phase 3 Trial for Niemann-Pick Disease Type C Isabella Ciccone, MPH

Findings from the phase 3 TransportNPC study showed that Trappsol Cyclo missed the primary end point in Niemann-Pick type C, but subgroup and survival data support planned 2026 NDA.

NeurologyLive® Friday 5 — October 2, 2026 Isabella Ciccone, MPH

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending October 2, 2026.

Latest News

— Patients in one place may get Medicare-paid procedures 10 times as often as elsewhere

— Local antibiotic implants during surgery may have helped shorten postoperative systemic regimens

Despite being a clinical scenario familiar to any rheumatologist, little evidence exists to guide treatment decisions for inflammatory arthritis limited to a single major joint.

AbbVie said on Thursday its therapy for a type of blood cancer has improved patients' response rate ⁠to treatment and reduced the risk of disease progression or death,...

For patients on methotrexate, routine monitoring every 6 months vs 3 months is not linked to an increase in laboratory or blood count abnormalities.

A recent diagnosis of gout is associated with an increased risk for fractures, and high adherence to allopurinol may help mitigate this elevated risk.

News All Time

Rare Case of Multiple Myeloma in Teenage Girl

Successful use of affordable induction therapy with autologous stem cell transplantation

Multi-Joint Arthritis Bodes Poorly for Healthy Aging

Osteoarthritis extent tied to increased frailty, even after adjusting for physical activity

Can Creatine Help Non-Athletes? A Physical Therapist Weighs In

Creatine may have less risk than other supplements, but who might benefit is unclear

Synovitis Confirmed as Prognostic in Hand Osteoarthritis, Regardless of Subtype

— Doesn't matter whether it's in the first carpometacarpal or interphalangeal joints

Denosumab May Protect Joints in Adults With Osteoporosis

Starting denosumab is associated with a modestly lower risk of developing osteoarthritis than starting oral bisphosphonates among adults with osteoporosis.

Straight Talk on Scoliosis Screening in Primary Care

Pediatricians can and should screen for scoliosis, especially in teens who are still growing.

Real-World Strategies to Improve Multidisciplinary Care Coordination of TGCT

Real-World Strategies to Improve Multidisciplinary Care Coordination of TGCT

Real-World Strategies to Improve Multidisciplinary Care Coordination of TGCT

Real-World Strategies to Improve Multidisciplinary Care Coordination of TGCT

Did Your Patient’s Cane Kill Them?

Mobility assistance devices may be harmful if not prescribed properly

Trial Casts Doubt on Antibiotics for Refractory Low Back Pain

Now it's up to clinicians to sort out conflicting evidence

GLP-1 Drugs Tied to Lower Need for Knee Replacement

But what drives the apparent effect remains unknown. Is it the weight loss or other factors?

Top Pro Athletes Credit a Tiny New Scope for Their Faster Recoveries

There's little published research, but a small, flexible arthroscope is accumulating proponents

Cancer Diagnosis Delays During Screening Study; Benefits of Resistance Training

Also in TTHealthWatch: GLP-1 agonists and knee replacement

Woman's Ice-Skating Fall Produces Striking X-Ray, Rare Forearm Break

While Monteggia fracture is uncommon in adults, early intervention is crucial

The World Cup Is a Celebration of Sport. It's Also a Warning About Climate Change.

The tournament is a preview for how outdoor activities are being reshaped globally

Why Some 'Old' Soccer Players Like Messi, Ronaldo Can Still Kick It in the World Cup

Advancements in training and recovery means elite athletes are playing longer than ever before

Recommended News For You

For relapsed or resistant DLBCL, odronextamab produced positive results.

Trial Supports Ivonescimab and Chemo for NSCLC Survival

Chemotherapy before surgery helps patients with nose and sinus cancer avoid debilitating eye and bone removal

Trump Issues Gag Order for CDC, FDA; Stalled Hearing for RFK Jr.; Sex After Cancer

Utilizing cerium/lanthanum-134 to improve cancer detection and treatment.

No Laughing Matter: Nitrous Oxide for Transrectal Prostate Biopsy.

Lesser-known lobular breast cancer on the rise in U.S. women

Recommended Articles For You

Beyond the Standard: Personalized Cancer Vaccines and the Dawn of a New Era in Pediatric Oncology 

The Technological Revolution in Precision Oncology and Tumor Microenvironment Therapy 

What Is Degos Disease? A Comprehensive Overview Of Symptoms, Diagnosis, and Treatment 

The Silent Killer: Uncovering the Causes and Treatments of Hemorrhagic Gastritis 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Datopotamab Deruxtecan Earns New Breast Cancer Indication

2.

Both DNA damage repair deficiency and non-Hodgkin lymphoma are the focus of LP-284.

3.

Clinical Evidence Shows Venetoclax Combo Is Safe and Effective in AML Patients 80 Years of Age and Up.

4.

The pancreatic ductal adenocarcinoma mRNA vaccine holds promise for preventing relapse.

5.

CAR T-Cell Therapy in Functional High-Risk Multiple Myeloma

1.

Engineered Red Blood Cell Therapeutics: Emerging Applications

2.

A New Hope: Exploring Treatment Options for Waldenstrom's Macroglobulinemia

3.

AI Meets the Gut Microbiome: Early Detection of GI Malignancies Redefined

4.

Biologic Therapies for Cutaneous Immune-Related Adverse Events in the Era of Immune Checkpoint Inhibitors

5.

Empowering Oncology with Data: Cloud Security, Real-World Evidence, and Clinical Insights

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

1.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV

2.

Chemotherapy: What to Expect

3.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V

4.

From Guidelines to Practice: Hematology

5.

Early Warning Signs of Cancer

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot